Clearmind Medicine Inc.Clearmind Medicine Inc.Clearmind Medicine Inc.

Clearmind Medicine Inc.

No trades
See on Supercharts
Market capitalization
‪5.52 M‬USD
−13.21USD
‪−8.62 M‬USD
‪3.01 M‬
Beta (1Y)
1.17

About Clearmind Medicine Inc.


CEO
Adi Zuloff-Shani
Headquarters
Vancouver
Founded
2017
FIGI
BBG01237P3C8
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CMND is 1.36 USD — it has decreased by −2.16% in the past 24 hours. Watch Clearmind Medicine Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Clearmind Medicine Inc. stocks are traded under the ticker CMND.
CMND stock has fallen by −11.69% compared to the previous week, the month change is a 13.33% rise, over the last year Clearmind Medicine Inc. has showed a −66.91% decrease.
CMND reached its all-time high on Nov 22, 2021 with the price of 657.00 USD, and its all-time low was 0.92 USD and was reached on Jan 23, 2024. View more price dynamics on CMND chart.
See other stocks reaching their highest and lowest prices.
CMND stock is 5.97% volatile and has beta coefficient of 1.17. Track Clearmind Medicine Inc. stock price on the chart and check out the list of the most volatile stocks — is Clearmind Medicine Inc. there?
Today Clearmind Medicine Inc. has the market capitalization of ‪4.41 M‬, it has decreased by −5.19% over the last week.
Yes, you can track Clearmind Medicine Inc. financials in yearly and quarterly reports right on TradingView.
CMND net income for the last quarter is ‪−2.09 M‬ USD, while the quarter before that showed ‪−908.22 K‬ USD of net income which accounts for −130.55% change. Track more Clearmind Medicine Inc. financial stats to get the full picture.
No, CMND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clearmind Medicine Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Clearmind Medicine Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Clearmind Medicine Inc. stock shows the sell signal. See more of Clearmind Medicine Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.